Family Office Of America (FOFA) Net Cash Flow Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 76.43% |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | -66.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.02% |
| Dec 31, 2025 | -235.77% |
| Sep 30, 2025 | 1,591.05% |
| Jun 30, 2025 | 172.61% |
| Mar 31, 2025 | 525.86% |
| Dec 31, 2024 | -313.87% |
| Sep 30, 2024 | 30.24% |
| Jun 30, 2024 | -424.04% |
| Mar 31, 2024 | 263.97% |
| Dec 31, 2023 | 92.16% |
| Sep 30, 2023 | 84.91% |
| Jun 30, 2023 | 104.95% |
| Mar 31, 2023 | 58.59% |
| Dec 31, 2022 | 41.87% |
| Sep 30, 2022 | 56.89% |